{"nct_id":"NCT03144687","title":"A Study of Itacitinib in Combination With Low-Dose Ruxolitinib or Itacitinib Alone Following Ruxolitinib in Participants With Myelofibrosis","status":"COMPLETED","status_verified_date":"2022-05","start_date":"2018-01-26","start_date_type":"ACTUAL","primary_completion_date":"2020-03-14","primary_completion_date_type":"ACTUAL","completion_date":"2021-06-01","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["INCY"]}